---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-004520"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2024-01-18T23:59:59+00:00"
generated_at: "2026-06-06T22:05:30.182136+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pasithea regains Nasdaq minimum bid price compliance, delisting risk removed

## Summary
- Received Nasdaq letter on Jan 17, 2024 confirming compliance with $1.00 minimum bid price rule.
- Stock held closing bid at or above $1.00 for sufficient consecutive business days to satisfy requirement.
- Previously received non-compliance notice on Jan 19, 2023 and extension to Jan 15, 2024.
- Matter is now closed; no further action needed regarding bid price deficiency.

## SEC filing metadata
- accession: 0001213900-24-004520
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2024-01-18T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390024004520/0001213900-24-004520-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390024004520/ea191820-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-004520
- JSON: https://secwatch.observer/filing/0001213900-24-004520.json
- Plain text: https://secwatch.observer/filing/0001213900-24-004520.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.